US Stock MarketDetailed Quotes

Pasithea Therapeutics (KTTA)

Watchlist
  • 0.6900
  • +0.0007+0.10%
Close Apr 24 16:00 ET
  • 0.6700
  • -0.0200-2.90%
Post 19:23 ET
17.21MMarket Cap-0.24P/E (TTM)

Pasithea Therapeutics (KTTA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
46.37%20.86M
214.65%10.26M
3.51%3.11M
-3.40%3.81M
-8.92%3.68M
-10.82%14.25M
-36.69%3.26M
-20.71%3M
3.04%3.95M
25.78%4.04M
Selling and administrative expenses
82.60%12.88M
329.34%7.51M
23.12%1.75M
4.74%1.66M
-14.89%1.95M
-10.50%7.05M
-2.65%1.75M
-34.25%1.42M
-11.86%1.59M
8.29%2.29M
-General and administrative expense
82.60%12.88M
329.34%7.51M
23.12%1.75M
4.74%1.66M
-14.89%1.95M
-10.50%7.05M
-2.65%1.75M
-34.25%1.42M
-11.86%1.59M
--2.29M
Research and development costs
10.87%7.98M
81.77%2.74M
-14.14%1.36M
-8.88%2.15M
-1.10%1.73M
-11.14%7.2M
-54.95%1.51M
-2.67%1.58M
16.26%2.36M
59.55%1.75M
Operating profit
-46.37%-20.86M
-214.65%-10.26M
-3.51%-3.11M
3.40%-3.81M
8.92%-3.68M
10.82%-14.25M
36.69%-3.26M
20.71%-3M
-3.04%-3.95M
-25.78%-4.04M
Net non-operating interest income expense
-22.68%327.19K
126.29%182.13K
-42.20%43.4K
-52.43%54.42K
-69.16%47.25K
1.88%423.18K
-53.43%80.48K
-43.01%75.08K
-2.38%114.41K
2,498.53%153.22K
Non-operating interest income
-22.68%327.19K
126.29%182.13K
-42.20%43.4K
-52.43%54.42K
-69.16%47.25K
1.88%423.18K
-53.43%80.48K
-43.01%75.08K
-2.38%114.41K
--153.22K
Other net income (expense)
231.63%102.42K
-2,719.77%-36.83K
141.59%29.24K
213.18%40.32K
160.88%69.7K
-238.33%-77.81K
102.54%1.41K
-256.25%-70.31K
-131.41%-35.62K
157.00%26.72K
Gain on sale of security
-257.44%-278.11K
-27,787.27%-389.28K
129.33%20.62K
158.54%20.85K
160.88%69.7K
-238.33%-77.81K
102.54%1.41K
-256.25%-70.31K
-131.41%-35.62K
157.00%26.72K
Other non- operating income (expenses)
--380.53K
--352.45K
--8.62K
--19.46K
----
----
----
----
----
----
Income before tax
-46.91%-20.43M
-218.19%-10.11M
-1.25%-3.04M
3.88%-3.72M
7.71%-3.56M
10.34%-13.9M
36.84%-3.18M
16.96%-3M
-7.45%-3.87M
-18.22%-3.86M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-46.91%-20.43M
-218.19%-10.11M
-1.25%-3.04M
3.88%-3.72M
7.71%-3.56M
12.89%-13.9M
37.05%-3.18M
16.96%-3M
-2.74%-3.87M
-9.13%-3.86M
Net income continuous Operations
-46.91%-20.43M
-218.19%-10.11M
-1.25%-3.04M
3.88%-3.72M
7.71%-3.56M
10.34%-13.9M
36.84%-3.18M
16.96%-3M
-7.45%-3.87M
-18.22%-3.86M
Net income discontinuous operations
----
----
----
----
----
--0
--0
--0
--0
--0
Minority interest income
Net income attributable to the parent company
-46.91%-20.43M
-218.19%-10.11M
-1.25%-3.04M
3.88%-3.72M
7.71%-3.56M
12.89%-13.9M
37.05%-3.18M
16.96%-3M
-2.74%-3.87M
-9.13%-3.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-46.91%-20.43M
-218.19%-10.11M
-1.25%-3.04M
3.88%-3.72M
7.71%-3.56M
12.89%-13.9M
37.05%-3.18M
16.96%-3M
-2.74%-3.87M
-9.13%-3.86M
Basic earnings per share
77.07%-2.91
81.83%-0.4379
85.71%-0.41
82.21%-0.66
56.49%-1.61
2.46%-12.69
46.92%-2.41
0.00%-2.87
-28.82%-3.71
-32.14%-3.7
Diluted earnings per share
77.07%-2.91
81.83%-0.4379
85.71%-0.41
82.21%-0.66
56.49%-1.61
2.46%-12.69
46.92%-2.41
0.00%-2.87
-28.82%-3.71
-32.14%-3.7
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 46.37%20.86M214.65%10.26M3.51%3.11M-3.40%3.81M-8.92%3.68M-10.82%14.25M-36.69%3.26M-20.71%3M3.04%3.95M25.78%4.04M
Selling and administrative expenses 82.60%12.88M329.34%7.51M23.12%1.75M4.74%1.66M-14.89%1.95M-10.50%7.05M-2.65%1.75M-34.25%1.42M-11.86%1.59M8.29%2.29M
-General and administrative expense 82.60%12.88M329.34%7.51M23.12%1.75M4.74%1.66M-14.89%1.95M-10.50%7.05M-2.65%1.75M-34.25%1.42M-11.86%1.59M--2.29M
Research and development costs 10.87%7.98M81.77%2.74M-14.14%1.36M-8.88%2.15M-1.10%1.73M-11.14%7.2M-54.95%1.51M-2.67%1.58M16.26%2.36M59.55%1.75M
Operating profit -46.37%-20.86M-214.65%-10.26M-3.51%-3.11M3.40%-3.81M8.92%-3.68M10.82%-14.25M36.69%-3.26M20.71%-3M-3.04%-3.95M-25.78%-4.04M
Net non-operating interest income expense -22.68%327.19K126.29%182.13K-42.20%43.4K-52.43%54.42K-69.16%47.25K1.88%423.18K-53.43%80.48K-43.01%75.08K-2.38%114.41K2,498.53%153.22K
Non-operating interest income -22.68%327.19K126.29%182.13K-42.20%43.4K-52.43%54.42K-69.16%47.25K1.88%423.18K-53.43%80.48K-43.01%75.08K-2.38%114.41K--153.22K
Other net income (expense) 231.63%102.42K-2,719.77%-36.83K141.59%29.24K213.18%40.32K160.88%69.7K-238.33%-77.81K102.54%1.41K-256.25%-70.31K-131.41%-35.62K157.00%26.72K
Gain on sale of security -257.44%-278.11K-27,787.27%-389.28K129.33%20.62K158.54%20.85K160.88%69.7K-238.33%-77.81K102.54%1.41K-256.25%-70.31K-131.41%-35.62K157.00%26.72K
Other non- operating income (expenses) --380.53K--352.45K--8.62K--19.46K------------------------
Income before tax -46.91%-20.43M-218.19%-10.11M-1.25%-3.04M3.88%-3.72M7.71%-3.56M10.34%-13.9M36.84%-3.18M16.96%-3M-7.45%-3.87M-18.22%-3.86M
Income tax 0000000000
Net income -46.91%-20.43M-218.19%-10.11M-1.25%-3.04M3.88%-3.72M7.71%-3.56M12.89%-13.9M37.05%-3.18M16.96%-3M-2.74%-3.87M-9.13%-3.86M
Net income continuous Operations -46.91%-20.43M-218.19%-10.11M-1.25%-3.04M3.88%-3.72M7.71%-3.56M10.34%-13.9M36.84%-3.18M16.96%-3M-7.45%-3.87M-18.22%-3.86M
Net income discontinuous operations ----------------------0--0--0--0--0
Minority interest income
Net income attributable to the parent company -46.91%-20.43M-218.19%-10.11M-1.25%-3.04M3.88%-3.72M7.71%-3.56M12.89%-13.9M37.05%-3.18M16.96%-3M-2.74%-3.87M-9.13%-3.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -46.91%-20.43M-218.19%-10.11M-1.25%-3.04M3.88%-3.72M7.71%-3.56M12.89%-13.9M37.05%-3.18M16.96%-3M-2.74%-3.87M-9.13%-3.86M
Basic earnings per share 77.07%-2.9181.83%-0.437985.71%-0.4182.21%-0.6656.49%-1.612.46%-12.6946.92%-2.410.00%-2.87-28.82%-3.71-32.14%-3.7
Diluted earnings per share 77.07%-2.9181.83%-0.437985.71%-0.4182.21%-0.6656.49%-1.612.46%-12.6946.92%-2.410.00%-2.87-28.82%-3.71-32.14%-3.7
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More